Efficacy and Safety of ALSS Treatment for ICIs-LF in Patients With HCC

NCT05484908 · clinicaltrials.gov ↗

NA

Phase

RECRUITING

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Immune-Mediated Hepatitis
Liver Failure
Hepatocellular Carcinoma

Interventions

OTHER: DPMAS+LPE
OTHER: PE
OTHER: Comprehensive internal medical treatment

Sponsor

Third Affiliated Hospital, Sun Yat-Sen University